Ocrevus 300mg/10ml Injection (Ocrelizumab) in Gujranwala - 03000291557 Ocrevus 300mg/10ml Injection (Ocrelizumab) in Pakistan Ocrevus 300mg/10ml Injection (Ocrelizumab) is a prescription medicine used as a disease-modifying treatment for certain forms of multiple sclerosis (MS). Ocrevus contains ocrelizumab, a humanized monoclonal antibody that targets CD20-positive B cells involved in the immune response associated with multiple sclerosis. The medicine is supplied as a 300mg/10ml concentrate for intravenous (IV) infusion in a single-dose vial. Ocrevus is used for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis according to the applicable prescribing information. Roche Pakistan lists Ocrevus 300mg/10ml Injection as a registered product in Pakistan. If you are looking for Ocrevus 300mg/10ml Injection in Pakistan, visit winerclick.com for product information and availability. Ocrevus 300mg/10ml Usage Ocrevus is used under the supervision of a qualified healthcare professional for the treatment of specified forms of multiple sclerosis. It is administered through an intravenous infusion, not as a medicine for self-injection at home. For adults and eligible pediatric patients weighing 35kg or more, the initial Ocrevus treatment consists of 300mg by IV infusion followed by another 300mg infusion two weeks later. Subsequent treatment is generally a 600mg IV infusion every six months, according to the current U.S. prescribing information. Before treatment, healthcare professionals screen for hepatitis B and assess immunoglobulins and certain liver-related laboratory tests. Patients are also premedicated before each infusion and monitored during and after administration. The exact treatment plan must always be determined by the treating neurologist. Benefits of Ocrevus 300mg/10ml The main therapeutic benefit of Ocrevus (ocrelizumab) is its role in modifying disease activity in certain forms of multiple sclerosis. It is approved for relapsing forms of MS and primary progressive MS in adults, while current U.S. labeling also includes relapsing MS in certain pediatric patients aged 10 years and older. By targeting CD20-positive B cells, Ocrevus is intended to reduce immune-system activity that contributes to MS disease activity. Clinical use focuses on reducing relapses and disease activity and slowing disability progression where supported by the applicable indication. Ocrevus is not described as a cure for multiple sclerosis, and treatment decisions should be made by a neurologist based on the patient's individual condition. How Ocrevus Works Ocrevus works by targeting CD20-positive B cells, a specific type of immune cell that can contribute to the inflammatory processes involved in multiple sclerosis. Ocrelizumab is a monoclonal antibody that binds to the CD20 protein found on certain B cells. This leads to depletion of these targeted B cells, while stem cells and plasma cells do not express CD20 and are not directly targeted in the same way. By reducing this particular B-cell population, Ocrevus can reduce immune activity associated with MS. Because the medicine affects the immune system, patients require medical monitoring for infections, infusion reactions and changes in immunoglobulin levels during treatment. Ocrevus 300mg/10ml Ingredients The active ingredient in Ocrevus 300mg/10ml Injection is ocrelizumab. Each 10ml vial contains a total of 300mg ocrelizumab, equivalent to a concentration of 30mg/ml. Roche product information lists excipients including sodium acetate trihydrate, glacial acetic acid, trehalose dihydrate, polysorbate 20 and water for injection. The product is supplied as a clear or slightly opalescent, colorless to pale-brown solution and is provided as a single-use formulation. Ocrevus does not contain a preservative according to the referenced product information. Ocrevus 300mg/10ml Specifications Product Name: Ocrevus 300mg/10ml Injection Generic Name: Ocrelizumab Strength: 300mg/10ml Concentration: 30mg/ml Dosage Form: Concentrate for solution for infusion Route: Intravenous (IV) infusion Pack: Single-dose vial Active Ingredient: Ocrelizumab Therapeutic Class: CD20-directed monoclonal antibody Main Indication: Certain relapsing forms of multiple sclerosis and primary progressive multiple sclerosis, according to applicable prescribing information Manufacturer: Roche Pakistan Status: Ocrevus 300mg/10ml is listed in Roche Pakistan's registered product information. Important Safety Information Ocrevus is a prescription medicine and should only be started and administered under appropriate medical supervision. Important risks include infusion reactions and infections. Current prescribing information recommends screening for hepatitis B before treatment and monitoring immunoglobulin levels. Ocrevus should not be given to patients with active hepatitis B infection or a history of a life-threatening infusion reaction to Ocrevus. Treatment may need to be delayed if a patient has an active infection. The current prescribing information also contains warnings regarding serious infections, reduced immunoglobulins, certain malignancies, liver injury and other adverse reactions. Patients should tell their neurologist about all medicines, vaccines, infections and medical conditions before treatment. Ocrevus 300mg/10ml Injection in Pakistan If you are searching for Ocrevus 300mg/10ml Injection price in Pakistan, Ocrevus 300mg/10ml online Pakistan, Ocrelizumab injection Pakistan, or Ocrevus for multiple sclerosis, product information can be found through winerclick.com. Availability, prescription requirements and pricing may vary. Since Ocrevus is a specialized prescription infusion medicine, patients should purchase and use it only through appropriate licensed medical and pharmaceutical channels and follow their neurologist's instructions. Short Description Ocrevus 300mg/10ml Injection contains ocrelizumab, a CD20-directed monoclonal antibody used for certain forms of multiple sclerosis. It is supplied as a 300mg/10ml single-dose vial for intravenous infusion under medical supervision. Ocrevus is used for relapsing forms of MS and primary progressive MS according to applicable prescribing information. For Ocrevus 300mg/10ml Injection in Pakistan, visit winerclick.com